Carregant...
Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products
Smoking is the major cause of lung cancer. While the risk of lung cancer increases with the number of cigarettes smoked and the duration of smoking, it also decreases upon smoking cessation. The development of candidate modified risk tobacco products (cMRTP) is aimed at providing smokers who will no...
Guardat en:
| Publicat a: | Intern Emerg Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6722152/ https://ncbi.nlm.nih.gov/pubmed/30767158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11739-019-02045-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|